1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow DC-806: new trials by email Literature Review of DC-806 trials Research Report on DC-806
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis DC-806, Placebo - Plaque Psoriasis | Phase 2 | Completed | DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company | 229 | 2023-05-02 | 2025-04-04 |
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company (1)
Canada (1) · Czechia (1) · Germany (1) · Hungary (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)